TORNADO THERAPEUTICS
Dead / Abandoned — Abandoned — no statement of use filed (as of 13 Jan 2025)
What this means for you
This application is over — abandoned 13 Jan 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97334141
- Mark type
- Stylized text
- Filed
- 28 Mar 2022
- Published for opposition
- 18 Apr 2023
- Abandoned
- 13 Jan 2025
- Attorney of record
- Carl Eppler
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the prevention of age-related physical decline, age-related diseases, infectious diseases, and Covid-19; pharmaceutical preparations and substances for the treatment of autoimmune diseases and inflammatory conditions, infectious diseases, fungal infections, mitochondrial myopathy and mitochondrial stress, oncology indications, metabolic indications, cardiovascular indications, neurodegenerative indications, and indications mediated by the mTOR pathway
Owner
- Cambrian BioPharma, Inc., New York, NY, US
- Cambrian BioPharma, Inc., New York, NY, US
Prosecution history
- 13 Jan 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 13 Jan 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 09 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 May 2024 — CORRECTED NOA E-MAILED
- 08 May 2024 — SOU EXTENSION 2 GRANTED
- 08 Apr 2024 — SOU EXTENSION 2 FILED
- 08 May 2024 — DIVISIONAL PROCESSING COMPLETE
- 08 Apr 2024 — DIVISIONAL REQUEST RECEIVED
- 29 Apr 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Apr 2024 — TEAS REQUEST TO DIVIDE RECEIVED
- 04 Apr 2024 — SOU TEAS EXTENSION RECEIVED
- 14 Dec 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Dec 2023 — SOU EXTENSION 1 GRANTED
- 12 Dec 2023 — SOU EXTENSION 1 FILED
- 12 Dec 2023 — SOU TEAS EXTENSION RECEIVED